Exogenous CTRP3 pretreatment (adenovirus-delivered or recombinant CTRP3) showed increased preservation and improved cardiac function in animal models of MI (Wurm et al., 2007; Wu et al., 2015). This evidence concerns the gene C1QTNF3 and myocardial infarction.